Founded
31 Dec 1985
Address
Domain Associates LLC
12481 High Bluff Drive
Suite 150
San Diego, CA 92130
United States
Phone
Website
Industry
VCID: 31340
Profile
Corporate information
Official name
Domain Associates, LLC
Registration country
Official name
Domain Associates, LLC
Registration country
Investment activity status
Active investor
Company type
Venture capital firm focused on life sciences companies.Funds managed
| Fund | Type | Vintage |
|---|---|---|
| Domain Partners IX LP | Venture | 2016 |
Investments
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Chromacode Inc High-definition PCR technology which enhances the multiplexing capabilities on existing hardware. |
United States | 11 May 2020 | Series C Initial investment. Round participant. Active |
|
|
Astute Medical Inc Dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers |
United States | 1 Jun 2012 1 Mar 2011 |
Series C |
|
|
|
Benvenue Medical Inc Engages in the design, manufacture, and marketing of medical devices for use in minimally invasive spinal therapies. |
United States | 1 Apr 2011 1 Jun 2012 |
Series D |
|
|
|
Kona Medical Inc Developer of non-invasive treatment for hypertension |
United States | 1 May 2012 | Series C Active |
|
|
|
Sequent Medical Inc A medical device company that is dedicated to the development of innovative catheter-based devices for neurovascular specialists and their patients |
United States | 1 Mar 2012 1 May 2010 |
Series C |
|
|
|
IntegenX Inc Developing equipment for molecular diagnostics |
United States | 1 Dec 2011 1 Feb 2011 |
Series C |
|
|
|
CoLucid Pharmaceuticals Biopharmaceutical company developing therapeutics to treat neurological dysfunctions. |
United States | 1 Aug 2011 | N/A |
|
|
|
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Oct 2010 | Series F |
||
|
|
aTyr Pharma Inc |
United States | 1 Oct 2010 | Series C Active |
|
|
|
Celator Pharmaceuticals Identifies ratios of synergistic drug combinations in vitro, and fixes ratios in liposomal drug carriers for in vivo treatment of various cancers. |
United States | 1 Sep 2010 | Series D Active |
|
|
|
Tobira Therapeutics Inc Dedicated to the clinical development of antiviral products |
United States | 1 Sep 2010 | Series B |
|
|
|
Veracyte Inc |
United States | 11 Jun 2010 | Series B |
|
|
|
Altair Therapeutics Inc Developing novel therapeutics to treat human respiratory diseases. |
United States | 1 Feb 2010 1 Nov 2009 |
Series B Repeat investment., Active |
|
|
|
Microchip Biotechnologies Inc |
United States | 12 Nov 2009 | Series B |
|
|
Zogenix Inc A pharmaceutical company, engages in the development and commercialization of products for the treatment of central nervous system disorders and pain. |
United States | 1 Sep 2009 | Series B Follow-on investment. Round participant. Active |